Origin of circulating free DNA in sepsis: Analysis of the CLP mouse model

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Hamaguchi, Shigeto ^a,b   Akeda, Yukihiro ^b   Yamamoto, Norihisa ^a,b   Seki, Masafumi ^a   Yamamoto, Kouji ^a   Oishi, Kazunori ^b,c   Tomono, Kazunori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CIRCULATING FREE DNA; DNA; HISTONE H3; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LY6G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL LOAD; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACELLULAR TRAP; MOUSE; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; LIGATION; SEPSIS;

MUS;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; LIGATION; MICE; MICE, INBRED C57BL; NEUTROPHILS; SEPSIS;

EID: 84939142578     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/614518     Document Type: Article

References (32)

1. M. M. Levy, A. Artigas, G. S. Phillips, et al., "Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study," The Lancet Infectious Diseases, vol. 12, no. 12, pp. 919-924, 2012.
2. B. D. Winters, M. Eberlein, J. Leung, D. M. Needham, P. J. Pronovost, and J. E. Sevransky, "Long-term mortality and quality of life in sepsis: a systematic review," Critical Care Medicine, vol. 38, no. 5, pp. 1276-1283, 2010.
3. T. M. Perl, L. Dvorak, T. Hwang, and R. P. Wenzel, "Long-term survival and function after suspected gram-negative sepsis," Journal of the American Medical Association, vol. 274, no. 4, pp. 338-345, 1995.
4. R. P. Dellinger, M. M. Levy, J. M. Carlet, et al., "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008," Critical Care Medicine, vol. 36, no. 1, pp. 296-327, 2008.
5. T. van der Poll and S. M. Opal, "Host-pathogen interactions in sepsis," The Lancet Infectious Diseases, vol. 8, no. 1, pp. 32-43, 2008.
6. K. Reinhart, M. Bauer, N. C. Riedemann, and C. S. Hartog, "Newapproaches to sepsis:molecular diagnostics and biomarkers," Clinical Microbiology Reviews, vol. 25, no. 4, pp. 609-634, 2012.
7. S. Margraf, T. Lögters, J. Reipen, J. Altrichter, M. Scholz, and J. Windolf, "Neutrophil-derived circulating free DNA (CFDNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis," Shock, vol. 30, no. 4, pp. 352-358, 2008.
8. T. Lögters, A. Paunel-Görgülü, C. Zilkens, et al., "Diagnostic accuracy of neutrophil-derived circulating free DNA (cf-DNA/NETs) for septic arthritis," Journal of Orthopaedic Research, vol. 27, no. 11, pp. 1401-1407, 2009.
9. V. Swarup and M. R. Rajeswari, "Circulating (cell-free) nucleic acids-a promising, non-invasive tool for early detection of several human diseases," FEBS Letters, vol. 581, no. 5, pp. 795-799, 2007.
10. J. Altrichter, S. Zedler, R. Kraft, et al., "Neutrophil-derived circulating free DNA (cf-DNA/NETs), a potential prognostic marker for mortality in patients with severe burn injury," European Journal of Trauma and Emergency Surgery, vol. 36, no. 6, pp. 551-557, 2010.
11. V. Brinkmann, U. Reichard, C. Goosmann, et al., "Neutrophil extracellular traps kill bacteria," Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
12. T. Lögters, S. Margraf, J. Altrichter, et al., "The clinical value of neutrophil extracellular traps," Medical Microbiology and Immunology, vol. 198, no. 4, pp. 211-219, 2009.
13. C. F. Urban, U. Reichard, V. Brinkmann, and A. Zychlinsky, "Neutrophil extracellular traps capture and kill Cand ida albicans and hyphal forms," Cellular Microbiology, vol. 8, no. 4, pp. 668-676, 2006.
14. T. A. Fuchs, U. Abed, C. Goosmann, et al., "Novel cell death program leads to neutrophil extracellular traps," Journal of Cell Biology, vol. 176, no. 2, pp. 231-241, 2007.
15. Q. Remijsen, T. W. Kuijpers, E. Wirawan, S. Lippens, P. Vandenabeele, and T. V. Berghe, "Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality," Cell Death and Differentiation, vol. 18, no. 4, pp. 581-588, 2011.
16. I. Neeli, S. N. Khan, and M. Radic, "Histone deimination as a response to inflammatory stimuli in neutrophils," The Journal of Immunology, vol. 180, no. 3, pp. 1895-1902, 2008.
17. W. Meng, A. Paunel-Görgülü, S. Flohé, et al., "Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice," Critical Care, vol. 16, no. 4, article R137, 2012.
18. I. H. Chaudry, K. A. Wichterman, and A. E. Baue, "Effect of sepsis on tissue adenine nucleotide levels," Surgery, vol. 85, no. 2, pp. 205-211, 1979.
19. J. T. Muenzer, C. G. Davis, B. S. Dunne, J. Unsinger, W. M. Dunne, and R. S. Hotchkiss, "Pneumonia after cecal ligationand puncture: a clinically relevant two-hit model of sepsis," Shock, vol. 26, no. 6, pp. 565-570, 2006.
20. X. Y. Xue, M. D. Teare, I. Holen, Y. M. Zhu, and P. J. Woll, "Optimizing the yield and utility of circulating cell-free DNA from plasma and serum," Clinica Chimica Acta, vol. 404, no. 2, pp. 100-104, 2009.
21. G. Harms, A. C. Layton, H. M. Dionisi, et al., "Real-time PCR quantification of nitrifying bacteria in a municipal wastewater treatment plant," Environmental Science and Technology, vol. 37, no. 2, pp. 343-351, 2003.
22. V. Brinkmann, B. Laube, U. Abu Abed, C. Goosmann, and A. Zychlinsky, "Neutrophil extracellular traps: how to generate and visualize them," Journal of Visualized Experiments, no. 36, Article ID e1724, 2010.
23. J. M. Daley, A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina, "Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice," Journal of Leukocyte Biology, vol. 83, no. 1, pp. 64-70, 2008.
24. P. C. Y. Woo, S. K. P. Lau, J. L. L. Teng, H. Tse, and K.-Y. Yuen, "Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories," Clinical Microbiology and Infection, vol. 14, no. 10, pp. 908-934, 2008.
25. G. Sozzi, D. Conte, M. Leon, et al., "Quantification of free circulating DNA as a diagnosticmarker in lung cancer," Journal of Clinical Oncology, vol. 21, no. 21, pp. 3902-3908, 2003.
26. A. A. Kamat, F. Z. Bischoff, D. Dang, et al., "Circulating cellfree DNA: a novel biomarker for response to therapy in ovarian carcinoma," Cancer Biology &Therapy, vol. 5, no. 10, pp. 1369-1374, 2006.
27. S. Breitbach, S. Tug, and P. Simon, "Circulating cell-free DNA: an up-coming molecular marker in exercise physiology," Sports Medicine, vol. 42, no. 7, pp. 565-586, 2012.
28. K. Jung, M. Fleischhacker, and A. Rabien, "Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature," Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1611-1624, 2010.
29. Y. Wang, M. Li, S. Stadler, et al., "Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation," Journal of Cell Biology, vol. 184, no. 2, pp. 205-213, 2009.
30. S. Hamaguchi, T. Hirose, Y. Akeda, et al., "Identification of neutrophil extracellular traps in the blood of patients with systemic inflammatory response syndrome," Journal of International Medical Research, vol. 41, no. 1, pp. 162-168, 2013.
31. G. J. Fournié, J.-P. Courtin, F. Laval, et al., "Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours," Cancer Letters, vol. 91, no. 2, pp. 221-227, 1995.
32. S. R. Clark, A. C. Ma, S. A. Tavener, et al., "Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood," Nature Medicine, vol. 13, no. 4, pp. 463-469, 2007.